How long will a patient wake up after discontinuation of thiopental (barbiturate) IV infusion given for 28 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Time to Awakening After 28-Hour Thiopental Infusion

After a 28-hour thiopental infusion, expect awakening to take 48-72 hours or longer, with potential delays extending several days due to the drug's extensive tissue accumulation and saturation kinetics during prolonged administration. 1, 2

Pharmacokinetic Basis for Prolonged Recovery

Thiopental exhibits nonlinear (Michaelis-Menten) kinetics during prolonged infusion, meaning elimination becomes saturated and progressively slower as tissue stores accumulate. 1

  • After continuous infusion for 4-8 days at 3-4.5 mg/kg/h, the elimination half-life extends to 18-36 hours at the end of infusion, with predicted terminal half-lives of approximately 10 hours 1
  • The volume of distribution at steady state is 4.35 ± 1.83 L/kg, indicating massive tissue accumulation 1
  • Hepatic enzyme saturation reaches 35-85% during prolonged infusion, dramatically slowing clearance 1

Expected Timeline for 28-Hour Infusion

For a 28-hour infusion (shorter than the 4-8 day studies but still prolonged):

  • Initial awakening: Expect 48-72 hours minimum based on clinical experience with shorter high-dose infusions 3
  • Steady-state concentrations during infusion likely reached 30-50 mg/L depending on infusion rate 1
  • Clearance during prolonged infusion decreases to approximately 2.16 mL/min/kg (50% lower than after single doses) 2

Factors Prolonging Recovery Time

The following factors will extend awakening time beyond standard predictions: 1, 2, 4

  • Dose-dependent saturation: Higher infusion rates (>4 mg/kg/h) cause greater enzyme saturation and longer recovery 1
  • Individual variability: Clearance varies dramatically between patients (0.268 to 5.40 mL/min/kg), with interpatient coefficient of variation reaching 51% by day 7 4
  • Hepatic dysfunction: Any liver impairment further reduces already-saturated clearance 2
  • Hypothermia: If used for cerebral protection with therapeutic hypothermia, metabolism is further slowed 5

Clinical Monitoring Recommendations

Monitor the following parameters during the awakening period: 1, 2

  • Plasma thiopental concentrations: Levels >40 mg/L produce burst-suppression on EEG; awakening unlikely until levels drop below 20-30 mg/L 1
  • Neurologic examination: Serial assessments every 12-24 hours, recognizing that sedative effects persist far longer than predicted by single-dose kinetics 2
  • EEG monitoring: Burst-suppression patterns indicate continued excessive CNS depression 1

Critical Pitfall to Avoid

Do not assume awakening will follow standard single-dose half-life predictions (5-6 hours). 1, 2 The context-sensitive half-time after 28 hours of infusion is dramatically prolonged due to:

  • Massive redistribution from fat stores (where thiopental accumulates extensively) 1
  • Saturated hepatic metabolism requiring days to clear accumulated drug 1
  • Nonlinear kinetics making standard half-life calculations invalid 1

Practical Timeframe

For clinical planning after a 28-hour thiopental infusion: 3, 1, 2

  • Minimum expected: 48-72 hours to initial awakening
  • More realistic: 3-5 days for meaningful neurologic recovery
  • Worst case: Up to 7 days in patients with low clearance or high steady-state concentrations

This prolonged recovery is why thiopental has largely been replaced by shorter-acting agents like propofol for prolonged sedation, despite thiopental's superior efficacy for refractory status epilepticus (92% seizure control). 6

References

Research

Variability of thiopental clearance in routine critical care patients.

European journal of clinical pharmacology, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.